$MTLK
METALINK LTD

2023 Q4 Form 20-F Financial Statement

#000109690624000890 Filed on April 19, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$38.00K -$41.00K
YoY Change -7.32% -4.65%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $62.00K $15.00K
YoY Change 313.33% -137.5%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $62.00K $15.00K
YoY Change 313.33% -137.5%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 1.256M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $17.00K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.969M
YoY Change 3.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $166.0K
YoY Change -1.19%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $166.0K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$145.1M
YoY Change -0.04%
Common Stock $790.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $12.04M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $1.803M
YoY Change
Total Liabilities & Shareholders Equity $1.969M
YoY Change 3.14%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income $62.00K $15.00K
YoY Change 313.33% -137.5%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$18.00K -$15.00K
YoY Change 20.0% -62.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $17.00K $20.00K
YoY Change -15.0% -108.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$18.00K -$15.00K
Cash From Investing Activities $17.00K $20.00K
Cash From Financing Activities
Net Change In Cash -$1.000K $5.000K
YoY Change -120.0% -101.74%
FREE CASH FLOW
Cash From Operating Activities -$18.00K -$15.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001098462
CY2023 dei Document Period Start Date
DocumentPeriodStartDate
2023-01-01
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-30394
CY2023 dei Entity Registrant Name
EntityRegistrantName
Metalink Ltd.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L3
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Haaliya 24
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Beit-Yitzhak
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
4292000
CY2023 dei Entity Address Country
EntityAddressCountry
IL
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1255640 shares
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023 dei Auditor Firm
AuditorFirmId
2015
CY2023 dei Auditor Name
AuditorName
Barzily & Co.
CY2023 dei Auditor Location
AuditorLocation
Jerusalem, Israel
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1932000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1891000 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
20000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
0 usd
CY2023Q4 us-gaap Assets
Assets
1969000 usd
CY2022Q4 us-gaap Assets
Assets
1909000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
166000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
168000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
166000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
168000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2780707 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2780707 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1255640 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1255640 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
790000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
790000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158111000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158111000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145060000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145122000 usd
CY2023Q4 fil Treasury Stock Shares1
TreasuryStockShares1
1525067 shares
CY2022Q4 fil Treasury Stock Shares1
TreasuryStockShares1
1525067 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
12038000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
12038000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1803000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1741000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1969000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1909000 usd
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
6000 usd
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
10000 usd
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
7000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-38000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-41000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-43000 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
100000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
56000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
62000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-40000 usd
CY2023 fil Basic And Diluted Profit Loss
BasicAndDilutedProfitLoss
0.049
CY2022 fil Basic And Diluted Profit Loss
BasicAndDilutedProfitLoss
0.012
CY2021 fil Basic And Diluted Profit Loss
BasicAndDilutedProfitLoss
-0.032
CY2023 fil Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
1255640 shares
CY2022 fil Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
1255640 shares
CY2021 fil Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
1255640 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1766000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-40000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1726000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1741000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
62000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1803000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
62000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-40000 usd
CY2023 fil Deposit Revaluation
DepositRevaluation
-58000 usd
CY2022 fil Deposit Revaluation
DepositRevaluation
-36000 usd
CY2021 fil Deposit Revaluation
DepositRevaluation
-3000 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
20000 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40000 usd
CY2023 fil Payments For Deposit
PaymentsForDeposit
-17000 usd
CY2022 fil Payments For Deposit
PaymentsForDeposit
-20000 usd
CY2021 fil Payments For Deposit
PaymentsForDeposit
248000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-248000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-288000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
301000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13000 usd
CY2023 fil Interest Obtained During The Year
InterestObtainedDuringTheYear
78000 usd
CY2022 fil Interest Obtained During The Year
InterestObtainedDuringTheYear
8000 usd
CY2021 fil Interest Obtained During The Year
InterestObtainedDuringTheYear
6000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:85.05pt"><kbd style="position:absolute;font:11pt stHtmlOvrFontNm;margin-left:-28.35pt"><b>A.</b></kbd><span style="border-bottom:1px solid #000000"><b>Use of Estimates in Preparation of Financial Statements</b></span> </p> <p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:85.05pt;text-align:justify"> </p> <p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:85.05pt;text-align:justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:85.05pt"><kbd style="position:absolute;font:11pt stHtmlOvrFontNm;margin-left:-28.35pt"><b>E.</b></kbd><span style="border-bottom:1px solid #000000"><b>Concentrations of Credit Risk</b></span> </p> <p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:72pt"> </p> <p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:85.05pt;text-align:justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and bank deposits.</p> <p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:85.5pt"> </p> <p style="font:11pt stHtmlOvrFontNm;margin:0;margin-left:85.05pt;text-align:justify">As of December 31, 2023, the Company had cash and cash equivalents that totaled to $17 and short-term deposits totaling to $1,932, all of which are deposited in a major Israeli financial institution and which are uninsured. As of December 31, 2022, the Company had cash and cash equivalents that totaled to $18 and short-term deposits totaling to $1,891, all of which were deposited in a major Israeli financial institution and which are uninsured. The Company has not incurred any losses on these accounts. Management believes that the financial institutions holding the Company's cash and cash equivalents and its deposits are financially sound and, accordingly, minimal credit risk exists with respect to these investments. </p>
CY2023 us-gaap Payments For Royalties
PaymentsForRoyalties
260000 usd
CY2023Q4 fil Provision For Contingent Liabilities
ProvisionForContingentLiabilities
128000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14300 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3400 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9200 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-14300 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3400 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9200 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
233000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
206000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
200000 usd
CY2023Q4 fil Provision For Legal Claims
ProvisionForLegalClaims
128000 usd
CY2022Q4 fil Provision For Legal Claims
ProvisionForLegalClaims
128000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
38000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
40000 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
166000 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
168000 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
100000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
56000 usd
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
6000 usd
CY2023 fil Income Expense From Revaluation Of Deposits
IncomeExpenseFromRevaluationOfDeposits
0 usd
CY2022 fil Income Expense From Revaluation Of Deposits
IncomeExpenseFromRevaluationOfDeposits
0 usd
CY2021 fil Income Expense From Revaluation Of Deposits
IncomeExpenseFromRevaluationOfDeposits
-3000 usd
CY2023 fil Financial Income
FinancialIncome
100000 usd
CY2022 fil Financial Income
FinancialIncome
56000 usd
CY2021 fil Financial Income
FinancialIncome
3000 usd

Files In Submission

Name View Source Status
0001096906-24-000890-index-headers.html Edgar Link pending
0001096906-24-000890-index.html Edgar Link pending
0001096906-24-000890.txt Edgar Link pending
0001096906-24-000890-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mtlk-20231231.htm Edgar Link pending
mtlk-20231231.xsd Edgar Link pending
mtlk20f_1.jpg Edgar Link pending
mtlk_ex12.htm Edgar Link pending
mtlk_ex13.htm Edgar Link pending
mtlk_ex15.htm Edgar Link pending
mtlk_ex2z1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
mtlk-20231231_def.xml Edgar Link unprocessable
mtlk-20231231_cal.xml Edgar Link unprocessable
mtlk-20231231_lab.xml Edgar Link unprocessable
mtlk-20231231_pre.xml Edgar Link unprocessable
mtlk-20231231_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable